JP2013173796A5 - - Google Patents

Download PDF

Info

Publication number
JP2013173796A5
JP2013173796A5 JP2013117401A JP2013117401A JP2013173796A5 JP 2013173796 A5 JP2013173796 A5 JP 2013173796A5 JP 2013117401 A JP2013117401 A JP 2013117401A JP 2013117401 A JP2013117401 A JP 2013117401A JP 2013173796 A5 JP2013173796 A5 JP 2013173796A5
Authority
JP
Japan
Prior art keywords
chronic skin
connexin
polynucleotide
pluronic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013117401A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013173796A (ja
JP5911454B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013173796A publication Critical patent/JP2013173796A/ja
Publication of JP2013173796A5 publication Critical patent/JP2013173796A5/ja
Application granted granted Critical
Publication of JP5911454B2 publication Critical patent/JP5911454B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013117401A 2006-12-11 2013-06-03 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド Expired - Fee Related JP5911454B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87440406P 2006-12-11 2006-12-11
US60/874,404 2006-12-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009541370A Division JP5431949B2 (ja) 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015000248A Division JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Publications (3)

Publication Number Publication Date
JP2013173796A JP2013173796A (ja) 2013-09-05
JP2013173796A5 true JP2013173796A5 (https=) 2014-04-10
JP5911454B2 JP5911454B2 (ja) 2016-04-27

Family

ID=39386432

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009541370A Expired - Fee Related JP5431949B2 (ja) 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド
JP2013117401A Expired - Fee Related JP5911454B2 (ja) 2006-12-11 2013-06-03 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド
JP2015000248A Pending JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009541370A Expired - Fee Related JP5431949B2 (ja) 2006-12-11 2007-12-11 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015000248A Pending JP2015063565A (ja) 2006-12-11 2015-01-05 減損した創傷治癒の組成物としての抗コネキシンポリヌクレオチド

Country Status (15)

Country Link
US (5) US8063023B2 (https=)
EP (3) EP2543377A1 (https=)
JP (3) JP5431949B2 (https=)
KR (1) KR101521306B1 (https=)
CN (2) CN101835476B (https=)
AU (1) AU2007333535B2 (https=)
BR (1) BRPI0721094A2 (https=)
CA (1) CA2672220A1 (https=)
DK (1) DK2101791T3 (https=)
ES (1) ES2527131T3 (https=)
PL (1) PL2101791T3 (https=)
PT (1) PT2101791E (https=)
RU (1) RU2521329C2 (https=)
SI (1) SI2101791T1 (https=)
WO (1) WO2008073479A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102073629B1 (ko) 2005-02-03 2020-02-05 코다 테라퓨틱스 (엔지) 리미티드 항-코넥신 화합물 및 그의 용도
AU2007319811A1 (en) 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
EP2543377A1 (en) 2006-12-11 2013-01-09 Coda Therapeutics, INC. Anticonnexin polynucleotides as impaired wound healing compositions
US20080249044A1 (en) * 2007-04-03 2008-10-09 Masaya Tanaka Nucleic acid external skin formulation
WO2009075881A2 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
US20110092449A1 (en) * 2007-12-21 2011-04-21 Bradford James Duft Treatment of fibrotic conditions
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
CA2819810A1 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
GB201117538D0 (en) * 2011-10-11 2011-11-23 Royal Veterinary College The Methods
DK2819682T3 (en) 2012-03-01 2017-08-21 Firststring Res Inc TOPICAL GELLS CONTAINING ALPHA-CONNEXIN C-TERMINAL (ACT) PEPTIDES
WO2013148736A1 (en) * 2012-03-27 2013-10-03 Coda Therapeutics, Inc. Compositions and treatments based on cadherin modulation
US9156896B2 (en) * 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
EP3116996A4 (en) * 2014-03-14 2018-01-10 Ocunexus Therapeutics, Inc. Treatment of resistant lesions
CN107109410B (zh) 2014-08-22 2021-11-02 奥克兰联合服务有限公司 通道调节剂
US10450569B2 (en) * 2015-08-13 2019-10-22 Somagenics, Inc. Methods and compositions of short small hairpin RNAS and microRNAS for wound healing
EP3518847B1 (en) * 2016-09-27 2023-03-01 Smith & Nephew plc Wound closure devices with dissolvable portions
CA3061738A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
CN108588075A (zh) * 2018-05-03 2018-09-28 天德悦（北京）生物科技有限责任公司 人Cx43基因干扰序列、shRNA-Cx43病毒及低表达Cx43蛋白的细胞系
MX2023004631A (es) 2020-10-22 2023-07-20 Xequel Bio Inc Formulaciones peptidicas y usos oftalmicos de las mismas.
RU2754383C1 (ru) * 2020-12-07 2021-09-01 Федеральное Государственное Бюджетное Учреждение "Национальный Медицинский Исследовательский Центр Эндокринологии" Министерства Здравоохранения Российской Федерации (Фгбу "Нмиц Эндокринологии" Минздрава России) Способ лечения неинфицированного послеоперационного раневого дефекта стопы при отсутствии признаков критической ишемии конечности у больных с нейропатической и нейроишемической формой синдрома диабетической стопы

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0539594Y2 (https=) * 1988-08-05 1993-10-07
US5004810A (en) 1988-09-30 1991-04-02 Schering Corporation Antiviral oligomers
US5166195A (en) 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
GB9425930D0 (en) 1994-12-22 1995-02-22 Procter & Gamble Silicone compositions
EP0950060A4 (en) 1996-12-02 2000-07-05 Dyad Pharmaceutical Corp COUNTERSTRAIN INHIBITION OF HUMAN ADHESION MOLECULES
RU2147240C1 (ru) * 1998-02-16 2000-04-10 Рязанский областной клинический кожно-венерологический диспансер Препарат для лечения длительно незаживающих инфицированных язв и ран
EP2314321B1 (en) * 1999-01-27 2014-06-04 Coda Therapeutics, Inc. Formulations comprising antisense nucleotides to connexins
US7250397B2 (en) 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
JP2005509621A (ja) 2001-10-17 2005-04-14 ユニバーシティ オブ ウェールズ カレッジ オブ メディスン ギャップ結合ならびにｅｄｈｆ
CN1638790A (zh) * 2002-01-29 2005-07-13 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
KR101350837B1 (ko) * 2003-12-03 2014-01-14 코다 테라퓨틱스, 인크. 코넥신에 표적화된 안티센스 화합물 및 그의 사용 방법
DE102004027422A1 (de) 2004-06-04 2005-12-29 Boehringer Ingelheim Microparts Gmbh Vorrichtung zur Aufnahme von Blut und Abtrennung von Blutbestandteilen
RU2438696C2 (ru) 2004-12-21 2012-01-10 Маск Фаундейшн Фор Рисерч Дивелопмент Композиции и способы, используемые для ускорения заживления ран и регенерации тканей
KR102073629B1 (ko) 2005-02-03 2020-02-05 코다 테라퓨틱스 (엔지) 리미티드 항-코넥신 화합물 및 그의 용도
AU2007319811A1 (en) 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
EP2543377A1 (en) 2006-12-11 2013-01-09 Coda Therapeutics, INC. Anticonnexin polynucleotides as impaired wound healing compositions
WO2008151022A2 (en) 2007-05-31 2008-12-11 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
EP2245158A2 (en) 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
WO2009075881A2 (en) 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2013173796A5 (https=)
JP2012041342A5 (https=)
JP2011252020A5 (https=)
JP2020530857A5 (https=)
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
JP2013155188A5 (https=)
JP2015518818A5 (https=)
JP2015537000A5 (https=)
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
BR112015010703A2 (pt) composição farmacêutica formulada para administração; método de tratamento ou prevenção de uma doença ou condição susceptível a tratamento com um tocotrienol; método de estabilização e/ou controle de glicemia em um animal; método de minimização da dosagem exigida para atingir um efeito terapêutico pela administração de um tocotrienol em um animal; método de minimização da dosagem exigida para atingir um efeito terapêutico pela administração de um tocotrienol em um animal; método de aperfeiçoamento de resistência ao exercício em um animal; método de aperfeiçoamento da capacidade de exercício em um animal; e uso
JP2015516419A5 (https=)
ME02405B (me) Spojevi pirazola као inhibitori sglt1
RU2014112324A (ru) Применение органического соединения для лечения синдрома нунан
JP2012525358A5 (https=)
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor
TN2016000179A1 (en) Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor.
RU2014102494A (ru) Ретиноидные композиции местного применения и способы лечения состояний кожи
JP2013523789A5 (https=)
JP2020040998A5 (https=)
Bogachev et al. Bioflavonoids and their significance in angiology: focus on diosmin
EA201590936A1 (ru) Композиция левоноргестрела для оптимальной пероральной контрацепции с определенным содержанием левоноргестрела, режим дозирования и фармацевтический препарат
RU2014148062A (ru) Инъекционная фармацевтическая композиция декскетопрофена и трамадола
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с
EA201592261A1 (ru) Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой
CN106860602A (zh) 一种用于糖尿病人的药酒